Thymosin Alpha-1 (Tα1)
Typical Dosing Protocols (Research/Compounded Use Only) – Thymosin Alpha-1 (Tα1)
Common protocol: 1.6 mg subcutaneously twice weekly (e.g., Monday and Thursday). This is the most widely used maintenance dose for immune support.
Other reported ranges:
General wellness / preventive: 1.5 mg every 3–7 days or 2–3 times per week
Acute / intensive support: 1.5–3 mg daily for 5–14 days
Higher short-term: Up to 3–6.4 mg daily in some protocols (limited duration)
Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).
1.6 mg = 0.32 mL (32 units on U-100 insulin syringe)
3 mg = 0.6 mL (60 units)
Administration: Subcutaneous injection (abdomen or thigh). Morning or early evening is common.
Dosing is highly individualized based on goals (immune support, infection recovery, anti-aging) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
){kind=link}